Debio 1450: Phase II started

Debiopharm began a double-blind, placebo-controlled, U.S. Phase II trial to compare 2 doses of IV Debio 1450 given 12 hours apart followed by twice-daily oral Debio 1450 vs. 2 doses of IV vancomycin...